Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Psychol Health Med ; 28(2): 324-335, 2023 02.
Article in English | MEDLINE | ID: mdl-35057684

ABSTRACT

Patients with chronic spontaneous urticaria (CSU) have an increased risk of psychological distress. This cross-sectional study aimed to determine factors associated with psychological burden, quality of life (QoL) and patient satisfaction among adults living with CSU. Participants completed the self-administered Urticaria Activity Score-7 (UAS-7), Depression Anxiety Stress Scale (DASS 21), Dermatology Life Quality Index (DLQI), and Short Assessment Patient Satisfaction (SAPS) questionnaires. Multivariate logistic regression was used to determine the independent predictors of depression, anxiety, stress, QoL and patient satisfaction. From a total of 115 subjects with a median age of 42.6 years, range (19-89 years). 60.9% subjects reported moderate-to-severe CSU, 26.1% reported symptoms of depression, 54.8% had anxiety, 40.0% had stress, and 36.5% reported severely impaired QoL. The median UAS-7 score was 20 (IQR 11-27) while the median score of DLQI was 8 (IQR 4-13). The median score of SAPS was 20 (IQR 17-21). Low-income and severe disease were the significant predictors for depression while severe disease was predictive of impaired QoL and depression. Subjects who were diagnosed at older ages and those who required medical leave due to flares of CSU were less likely to be satisfied with their care. (192 words).


Subject(s)
Chronic Urticaria , Patient Satisfaction , Humans , Adult , Young Adult , Middle Aged , Aged , Aged, 80 and over , Quality of Life , Psychological Well-Being , Cross-Sectional Studies
2.
Photodermatol Photoimmunol Photomed ; 38(6): 541-547, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35324018

ABSTRACT

BACKGROUND: Airline pilots face significant ultraviolet radiation exposure resulting in an increased risk of sun damage and skin cancers. We aimed to evaluate sun-protective practices and associated factors among airline pilots. METHODS: We disseminated an online questionnaire evaluating the use of sunscreen, sunglasses, hats and protective clothing during daytime hours in the cockpit and during outdoor activities to 346 global commercial airline pilots, and we received 220 completed responses. The Pearson chi-squared test or Fisher's exact test where necessary were used to determine possible factors associated with the use of sun-protective practices. Potential confounders were adjusted for using multivariate analyses. RESULTS: The most common sun protective behaviour was the wearing of sunglasses during daytime flights (89.5%), followed by the use of caps during outdoor activities (47.7%). More pilots applied sunscreen during daytime flights (14.1%) compared with walk-arounds (8.2%). Males were less likely to use sunscreen during flights (adjusted odds ratio, aOR = 0.76), use sunscreen for walk-arounds (aOR = 0.175) and wear long sleeves (aOR = 0.013). Pilots who flew less than 30 h a month in high latitude regions were less likely to use a cap or hat outdoors (aOR = 0.419) or use sunscreen during walk-arounds (aOR = 0.241). Younger pilots were also less likely to use caps or hats outdoors (aOR = 0.446). CONCLUSION: Male pilots and those who spent less time in high latitudes were less likely to practice sun protection. Targeted educational efforts may be implemented to reduce occupational ultraviolet exposure.


Subject(s)
Pilots , Skin Neoplasms , Sunburn , Humans , Male , Sunscreening Agents/therapeutic use , Ultraviolet Rays/adverse effects , Protective Clothing , Skin Neoplasms/prevention & control , Skin Neoplasms/drug therapy , Sunburn/prevention & control
6.
Lepr Rev ; 85(3): 170-6, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25509717

ABSTRACT

OBJECTIVES: Leprosy remains a public health concern in Malaysia and globally. We aim to review the characteristics of leprosy patients in a tertiary institution in urban Malaysia. DESIGN: This is a case series of 27 leprosy patients who presented between 2008 and 2013. RESULTS: The majority of our patients consisted of male (74.1%), Malaysian (63.0%), blue collar workers (51.9%) and married (59.3%) patients; 48.1% had lepromatous leprosy. All except one of the patients presented with skin lesions, 25.9% had nerve involvement and 33.3% developed lepra reactions. Forty-four point four percent (44.4%) of the cases seen initially in the primary care setup were misdiagnosed. CONCLUSIONS: Doctors need to have a high index of suspicion for leprosy when patients present with suggestive skin, nerve or musculoskeletal lesions. Immigrants accounted for 37% of cases and these patients may become a reservoir of infection, thus accounting for the rise in incidence. An increasing trend in multibacillary cases may be attributed to the spread from migrants from countries with a high burden of leprosy.


Subject(s)
Leprosy/epidemiology , Travel , Adult , Aged , Asia/epidemiology , Female , Humans , Leprosy/diagnosis , Leprosy/ethnology , Malaysia/epidemiology , Malaysia/ethnology , Male , Middle Aged , Young Adult
7.
Epilepsia ; 55(11): e120-4, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25266342

ABSTRACT

This study aimed to investigate the prevalence and association of HLA-B*15:02 with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis (CBZ-SJS/TEN) in the Indian population in Malaysia, which mostly originated from Southern India. HLA-B alleles in five Indian case patients with CBZ-SJS/TEN and 52 CBZ-tolerant controls, and followed by a pooled sample of seven cases from two centers in Malaysia were analyzed. Positive association for HLA-B*15:02 with CBZ-SJS/TEN was detected in Indians (40% [2/5] vs. 3.8% [2/52], odds ratio [OR] 16.7, p = 0.0349), of which 80% (4/5) of the Indian patients originated from Southern India. A pooled sample of seven cases showed stronger association between HLA-B*15:02 and CBZ-SJS/TEN (57.1% [4/7] vs. 3.8% [2/52], OR 33.3, 95% confidence interval [CI] 4.25-162.21, p = 1.05 × 10(-3)). Subsequent meta-analysis on Indians from Malaysia and India further demonstrated a significant and strong association between HLA-B*15:02 and CBZ-SJS/TEN (OR 38.54; 95% CI 6.83-217.34, p < 1.0 × 10(-4)). Our study is the first on Indians predominantly from Southern India that demonstrated HLA-B*15:02 as a strong risk factor for CBZ-SJS/TEN despite a low population allele frequency. This stressed the importance of testing for HLA-B*15:02, irrespective of the ancestral background, including populations with low allele frequency.


Subject(s)
Carbamazepine/pharmacology , Gene Frequency/genetics , Genetic Predisposition to Disease , HLA-B15 Antigen/genetics , Stevens-Johnson Syndrome/epidemiology , Stevens-Johnson Syndrome/genetics , Adolescent , Adult , Aged , Asian People/genetics , Epidermis/immunology , Epidermis/pathology , Female , HLA-B15 Antigen/immunology , Humans , India , Male , Middle Aged , Necrosis/immunology , Risk Factors , Young Adult
9.
J Dermatol ; 40(11): 874-80, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24111816

ABSTRACT

Staphylococcus aureus is frequently found in patients with atopic dermatitis (AD) and contributes to disease exacerbation. The objective of this study was to evaluate the efficacy and safety of bleach baths as an adjunctive treatment in AD patients. Patients between 2 and 30 years old with moderate to severe AD were enrolled in a prospective, randomized, placebo-controlled study. Patients soaked in diluted bleach or distilled water baths for 10 min, twice a week for 2 months. Efficacy assessments included the Eczema Area and Severity Index (EASI) scores and S. aureus density was determined using quantitative bacterial cultures. Patients in the treatment group showed significant reductions in EASI scores. A 41.9% reduction in S. aureus density from baseline was seen at 1 month further reducing to 53.3% at 2 months. Equal numbers of patients in both groups experienced mild side-effects. This study demonstrates that diluted bleach baths clinically improved AD in as little as 1 month. No patient withdrew from the treatment arm because of intolerance to the baths.


Subject(s)
Baths/statistics & numerical data , Dermatitis, Atopic/therapy , Disinfectants/therapeutic use , Sodium Hypochlorite/therapeutic use , Staphylococcal Skin Infections/therapy , Adolescent , Baths/adverse effects , Child , Child, Preschool , Dermatitis, Atopic/complications , Dermatitis, Atopic/microbiology , Double-Blind Method , Female , Humans , Malaysia , Male , Prospective Studies , Staphylococcal Skin Infections/complications , Treatment Outcome , Young Adult
10.
Int J Dermatol ; 52(1): 102-5, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23278617

ABSTRACT

BACKGROUND: Methotrexate (MTX) is a common and efficacious systemic agent used for the treatment of moderate to severe psoriasis. Nevertheless, its use is associated with the risk of hepatotoxicity. This study was performed to study the association of MTX dose with regards to hepatotoxicity as evidenced by deranged transaminases. METHODS: This was a retrospective review of patients with psoriasis on MTX from 2000 to 2009 at the outpatient dermatology clinic, University Malaya Medical Centre (UMMC). We analyzed patients' demography, serial laboratory investigations, liver ultrasounds, and liver biopsies of patients on MTX. RESULTS: Sixty-six of 710 (9.30%) patients with psoriasis were prescribed MTX throughout the 10-year period. Among them 57.6% developed deranged transaminases, with six requiring MTX withdrawal due to hepatotoxicity. The mean cumulative dose of MTX at the detection of liver enzyme derangement was 552.3 ± 596.1 mg. CONCLUSION: A high proportion of patients on MTX had deranged transaminases. However, the number of serious events was low. We concluded from this study that the use of MTX is relatively safe in patients with moderate to severe psoriasis.


Subject(s)
Chemical and Drug Induced Liver Injury/etiology , Dermatologic Agents/adverse effects , Liver/drug effects , Methotrexate/adverse effects , Psoriasis/drug therapy , Adolescent , Adult , Aged , Female , Humans , Malaysia , Male , Middle Aged , Retrospective Studies , Severity of Illness Index , Tertiary Care Centers , Time Factors , Young Adult
12.
Australas J Dermatol ; 53(1): 81-3, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22309341

ABSTRACT

Methotrexate toxicity is known to cause erosions of existing psoriatic plaques, although rare. We describe two patients who developed painful ulcerated psoriatic plaques as an early presenting sign of methotrexate toxicity and review the risk factors associated with this manifestation.


Subject(s)
Dermatologic Agents/adverse effects , Methotrexate/adverse effects , Psoriasis/chemically induced , Skin Ulcer/chemically induced , Female , Humans , Male , Middle Aged , Psoriasis/diagnosis , Risk Factors , Skin Ulcer/diagnosis , Torso
13.
Int J Dermatol ; 51(2): 158-61, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22250623

ABSTRACT

BACKGROUND: Vitiligo is a chronic disease and can have significant impairment on patients' quality of life (QoL). Studies have shown that limitations in QoL are similar in magnitude to patients with other chronic skin diseases like psoriasis. The objective of this study was to assess the quality of life (QoL) of patients with vitiligo attending the dermatology clinic of a tertiary hospital in Malaysia. METHODS: All patients with a clinical diagnosis of vitiligo who were seen at our dermatology clinic and phototherapy daycare center from September 15 to November 20, 2009 were invited to participate. RESULTS: A total of 102 patients with vitiligo were included in this survey (56.9% females, 43.1% males; mean age 43.6). The mean DLQI score ± SD was 6.40 ± 5.17. The highest mean DLQI score was seen in the patient group aged 30-59 years (mean score 7.05). Malays had significantly higher DLQI scores compared with Indians (P = 0.026). CONCLUSION: Patients in our cohort showed a moderate limitation of QoL, comparable to that of other chronic skin diseases. Management should focus not only on medical treatment but also psychological aspects, hence better QoL and treatment outcomes.


Subject(s)
Quality of Life , Vitiligo/psychology , Adolescent , Adult , Aged , Aged, 80 and over , China/ethnology , Female , Humans , India/ethnology , Malaysia , Male , Middle Aged , Prospective Studies , Surveys and Questionnaires , Vitiligo/ethnology , Vitiligo/therapy , Young Adult
14.
Med Mycol ; 50(4): 404-6, 2012 May.
Article in English | MEDLINE | ID: mdl-22074310

ABSTRACT

Disseminated sporotrichosis is uncommon and usually occurs in patients who are immunodeficient. Here we describe a male patient who was otherwise in good physical condition, who presented with disseminated sporotrichosis. The only significant event in his past medical history was lepromatous leprosy which had been treated 42 years earlier.


Subject(s)
Sporotrichosis/diagnosis , Sporotrichosis/pathology , Histocytochemistry , Humans , Leprosy, Lepromatous/drug therapy , Male , Microscopy , Middle Aged , Skin/pathology
15.
Article in English | WPRIM (Western Pacific) | ID: wpr-626035

ABSTRACT

Syphilis is an ancient sex u a l ly transmitted infection, described since centuries ago, caused by the bacterium Treponema pallidum. Syphilis or luetic disease is known as the great imitator as it can have myriads of clinical presentations, often making it a diagnostic challenge to clinicians. We report a patient with secondary syphilis, wh o presented with scaly plaques on his trunk and face, sparing the palms and soles.

16.
Article in English | WPRIM (Western Pacific) | ID: wpr-626019

ABSTRACT

Background: Individuals with AD have an increased susceptibility to colonization with Staphylococcus aureus (S. aureus), contributing to the exacerbation of the disease. Sodium hypochlorite (bleach) has both in vitro and in vivo antimicrobial activity against S.aureus. Objectives: To evaluate the efficacy and safety of diluted sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in our Malaysian population. Methods: This was a prospective randomized, investigator-blinded, placebo-controlled study. Patients were randomly assigned through computer generated simple randomized numbers to treatment (bleach baths) or placebo (distilled water baths). Patients were instructed to soak in the baths neck down for 10 minutes, twice a week for 2 months. The efficacy outcome measures were the Eczema Area and Severity Index (EASI) score, percentage body surface area involved, quantitative S. aureus counts and patient’s assessment of overall response (including itch scores). Safety outcomes were also assessed. Results: A total of 36 patients completed the study. EASI scores and body surface area showed significant improvement between treatment and placebo groups at 2 months (p=0.02, p=0.02). At baseline, 88% of patients yielded S. aureus from lesional skin. Although most cultures in the treatment group continued to yield S. aureus, there was a reduction in the density over time, although not statistically significant. Five patients reported burning/stinging and dry skin in the treatment arm which did not differ significantly compared to placebo. Conclusion: Diluted sodium hypochlorite baths as an adjunctive treatment decreased the clinical severity of patients with moderate to severe atopic dermatitis and may reduce S. aureus density. This treatment was well tolerated with minimal adverse effects.

SELECTION OF CITATIONS
SEARCH DETAIL
...